Approach to Progressive Myoclonic Epilepsies: Clinical Clues for Genetic Testing.

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Progressive myoclonic epilepsy (PME) is a complex neurological disorder with diverse genetic causes.
• Accurate genetic testing is essential for diagnosing PME, but inappropriate testing can lead to significant diagnostic delays.
• The phenotypic variability and inheritance patterns can complicate the diagnostic process.

Purpose of the Study:

• To highlight the critical role of appropriate genetic testing in diagnosing rare neurological disorders like PME.
• To present a case study illustrating diagnostic challenges due to improper genetic testing.
• To propose a clinical decision-making flowchart to guide genetic test selection for PME.

Main Methods:

• Case study of an adult patient with a PME phenotype and a family history suggestive of spinocerebellar ataxia.
• Clinical evaluation focusing on neurological examination, family history, and disease progression.
• Genetic analysis, including polymerase chain reaction (PCR) testing of the *ATN1* gene, to identify trinucleotide repeat expansion.

Main Results:

• The patient remained undiagnosed for four years due to initial improper genetic testing.
• Clinical presentation, autosomal dominant inheritance, and anticipation strongly suggested dentatorubral-pallidoluysian atrophy (DRPLA).
• Confirmation of DRPLA through *ATN1* gene trinucleotide repeat expansion testing.

Conclusions:

• The selection of the correct genetic test is paramount for the accurate and timely diagnosis of PME.
• A systematic approach, utilizing clinical history and findings, can effectively narrow down differential diagnoses for PME.
• The proposed flowchart can aid clinicians in choosing the most appropriate genetic testing strategy for patients with PME phenotypes.